As of 2024-12-12, the EV/EBITDA ratio of S2Medical AB (publ) (S2M.ST) is 1.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. S2M.ST's latest enterprise value is 6.15 mil SEK. S2M.ST's TTM EBITDA according to its financial statements is 3.63 mil SEK. Dividing these 2 quantities gives us the above S2M.ST EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 1.7x - 1.7x | 1.7x |
| Forward P/E multiples | 1.7x - 1.7x | 1.7x |
| Fair Price | 0.01 - 0.01 | 0.01 |
| Upside | 0.3% - 0.3% | 0.3% |
| Date | EV/EBITDA |
| 2024-11-22 | 1.58 |
| 2024-11-21 | 1.58 |
| 2024-11-20 | 1.58 |
| 2024-11-19 | 1.92 |
| 2024-11-18 | 2.04 |
| 2024-11-15 | 2.27 |
| 2024-11-14 | 2.27 |
| 2024-11-13 | 2.16 |
| 2024-11-12 | 2.16 |
| 2024-11-11 | 2.50 |
| 2024-11-08 | 2.39 |
| 2024-11-07 | 2.62 |
| 2024-11-06 | 2.62 |
| 2024-11-05 | 2.62 |
| 2024-11-04 | 2.62 |
| 2024-11-01 | 3.08 |
| 2024-10-31 | 2.96 |
| 2024-10-30 | 3.19 |
| 2024-10-29 | 3.19 |
| 2024-10-28 | 3.19 |
| 2024-10-25 | 3.19 |
| 2024-10-24 | 3.54 |
| 2024-10-23 | 3.42 |
| 2024-10-22 | 3.31 |
| 2024-10-21 | 3.54 |
| 2024-10-18 | 3.54 |
| 2024-10-17 | 5.61 |
| 2024-10-16 | 5.61 |
| 2024-10-15 | 5.61 |
| 2024-10-14 | 5.15 |
| 2024-10-11 | 5.38 |
| 2024-10-10 | 6.30 |
| 2024-10-09 | 6.53 |
| 2024-10-08 | 5.72 |
| 2024-10-07 | 5.49 |
| 2024-10-04 | 4.92 |
| 2024-10-03 | 5.26 |
| 2024-10-02 | 4.23 |
| 2024-10-01 | 4.23 |
| 2024-09-30 | 4.34 |
| 2024-09-27 | 4.46 |
| 2024-09-26 | 4.69 |
| 2024-09-25 | 4.69 |
| 2024-09-24 | 4.92 |
| 2024-09-23 | 4.69 |
| 2024-09-20 | 5.49 |
| 2024-09-19 | 5.15 |
| 2024-09-18 | 5.15 |
| 2024-09-17 | 5.03 |
| 2024-09-16 | 4.80 |